Articles related to HEALTHCARE COSTS

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.

The annual cost of cancer screening represents a notable portion of overall U.S. health care system costs related to cancer, with private insurance covering the majority of expenses.

PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.

Telemedicine significantly enhances patient access to care by offering a wide range of services from general health to specialized treatments, all at potentially lower costs compared to traditional visits.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.